Colin Suckling, OBE BSc PhD DSc CChem FRSC FRCS(Glasg) Hon FRCS (Edin) FRSA FRSE

Prof

  • United Kingdom

1991 …2020
If you made any changes in Pure these will be visible here soon.

Personal profile

Personal Statement

Colin Suckling has been Freeland Professor of Chemistry at the University of Strathclyde since 1989. During the 1990s until 2002, he served successively as Dean of the Faculty of Science, Deputy Principal, and Vice Principal of the University of Strathclyde.  Much of Professor Suckling's work during that time was strategic including the development of inter-institutional and interdisciplinary research partnerships notably the research collaboration with the University of Glasgow (WestCHEM), which was recognized publicly with the award of OBE in 2006.

Recent and current research interests focus on the synthesis and properties of heterocyclic compounds designed as molecular probes for biological systems or as drugs.  Particular progress has been made in the field of fused pyrimidine compounds with anticancer and antiparasite activity and in the field of minor groove binders for DNA with antibacterial activity.  Several discoveries are entering pre-clinical development.

Professor Suckling's standing in the field of heterocyclic chemistry has been recognized by the award of the Adrien Albert Lectureship of the Royal Society of Chemistry (2009-10) and his appointment as chairman of the 2011 International Congress of Heterocyclic Chemistry to be held in Glasgow.

Fingerprint Dive into the research topics where Colin Suckling is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Binders Chemical Compounds
Helminths Medicine & Life Sciences
Pteridines Chemical Compounds
DNA Chemical Compounds
Acanthocheilonema Medicine & Life Sciences
Phosphorylcholine Medicine & Life Sciences
Thiazoles Medicine & Life Sciences
Ligands Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2020

A new drug discovery pipeline for animal African trypanosomiasis / R150401-2

Suckling, C. & Burley, G.

1/04/1630/09/19

Project: Research - Internally AllocatedResearch (Internally Allocated)

Research Output 1991 2019

Novel minor groove binders cure animal African trypanosomiasis in an in vivo mouse model

Giordani, F., Khalaf, A. I., Gillingwater, K., Munday, J. C., De Koning, H. P., Suckling, C. J., Barrett, M. P. & Scott, F. J., 28 Mar 2019, In : Journal of Medicinal Chemistry. 62, 6, p. 3021-3035 15 p.

Research output: Contribution to journalArticle

African Trypanosomiasis
Pentamidine
Trypanosoma congolense
Trypanosoma vivax
Africa South of the Sahara

Selective in vitro anti-cancer activity of non-alkylating minor groove binders

Nichol, R., Khalaf, A., Sooda, K., Hussain, O., Griffiths, H., Phillips, R., Javid, F., Suckling, C. J., Allison, S. & Scott, F., 18 Jul 2019

Research output: Contribution to journalArticle

Binders
Cell Line
Ovarian Neoplasms
Cisplatin
Carboplatin

Thesis

Analogues of BH4 and nitric oxide synthase activators

Author: Akbar, M. N., 1 Oct 2010

Supervisor: Suckling, C. (Supervisor) & (Supervisor)

Student thesis: Doctoral Thesis

An investigation into nucleic acid binding compounds

Author: Scott, F., 1 Oct 2012

Supervisor: Dufton, M. (Supervisor) & Suckling, C. (Supervisor)

Student thesis: Doctoral Thesis

Prizes

Gold medal of Indian Society of Chemists and Biologists

Colin Suckling (Recipient), Feb 2011

Prize: Prize (including medals and awards)

gold

Honorary Fellow of Royal College of Surgeons of Edinburgh

Colin Suckling (Recipient), 2005

Prize: Election to learned society

Scotland
Medicine
Surgeons

Activities 2007 2017

From blue sky research to big data- external perspectives on making knowledge work

Colin Suckling (Speaker)
Jun 2017

Activity: Talk or presentation typesInvited talk

There's no escape - single target, multiple effects

Colin Suckling (Speaker)
Mar 2015

Activity: Talk or presentation typesInvited talk

Impacts

MGB Biopharma licensed to treat deadly infections

Colin Suckling (Participant), Iain Hunter (Participant), Alan Harvey (Participant), Simon MacKay (Participant), Curtis G. Gemmell (Participant)

Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

File